IPO
-
-
-
-
-
-
-
Attovia Therapeutics prices IPO at $17 per share on Nasdaq
-
-
-
-
-
-
-
Atento Reports Fiscal 2017 First-Quarter Results Solid Start in Fiscal 2017 Highlighted by Topline Growth, Maintained Margins and Continued Improvement in Cash flow
-
-
-
-
-
-
-
Atento Reports Second Quarter Fiscal 2015 Results
-
-
-
-
-
125,295 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

